Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up
Article in Annals of Oncology (May 2019)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Annals of Oncology (May 2019)
Article in Bulletin du Cancer (April 2019)
Article in Bladder Cancer (April 2018)